PLAT and neoplasm: However, pretreatment with 3-epiCA and MA significantly reduced the overall tumor incidence (67% and 73%, respectively) and the reduction was statistically significant (p < 0.05, Fisher's exact test) when compared to TPA only group or the UA-pretreated group (both 97% incidence).